APO Research
Talk to an analyst

APO RESEARCH · REPORT

Haemophilus Influenzae Type B Injection Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Haemophilus Influenzae Type B Injection Vaccine Industry Growth and Trends Forecast to 2032

29 December 2025108 pages

Choose your research edition.

Industry ResearchHaemophilus Influenzae Type B Injection Vaccine Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Haemophilus Influenzae Type B Injection Vaccine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Haemophilus Influenzae Type B Injection Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Haemophilus Influenzae Type B Injection Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Haemophilus Influenzae Type B Injection Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Haemophilus Influenzae Type B Injection Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Haemophilus Influenzae Type B Injection Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Haemophilus Influenzae Type B Injection Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Haemophilus Influenzae Type B Injection Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Haemophilus Influenzae Type B Injection Vaccine include Bharat Biotech, Biokangtai, Glaxosmithkline, Olymvax, Sanofi Pasteur, Walvax Biotechnology, Beijing Minhai Biotechnology Co., Ltd, Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd and Chengdu Oulin Biotechnology Co., Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Haemophilus Influenzae Type B Injection Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Haemophilus Influenzae Type B Injection Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Haemophilus Influenzae Type B Injection Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Haemophilus Influenzae Type B Injection Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Haemophilus Influenzae Type B Injection Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Haemophilus Influenzae Type B Injection Vaccine Market by Company

Bharat Biotech

Biokangtai

Glaxosmithkline

Olymvax

Sanofi Pasteur

Walvax Biotechnology

Beijing Minhai Biotechnology Co., Ltd

Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd

Chengdu Oulin Biotechnology Co., Ltd

Chengdu Institute of Biological Products Co., Ltd

Lanzhou Institute of Biological Products Co., Ltd

Yuxi Watson Biotechnology Co., Ltd

Haemophilus Influenzae Type B Injection Vaccine Segment by Type

Lyophilized

Non-lyophilized

Haemophilus Influenzae Type B Injection Vaccine Segment by Application

Hospital

Clinic

Haemophilus Influenzae Type B Injection Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Haemophilus Influenzae Type B Injection Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Haemophilus Influenzae Type B Injection Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Haemophilus Influenzae Type B Injection Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Haemophilus Influenzae Type B Injection Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Haemophilus Influenzae Type B Injection Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Lyophilized Table 2. Major Company of Non-lyophilized Table 3. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2026) & (K Units) Table 5. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Haemophilus Influenzae Type B Injection Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2027-2032) & (K Units) Table 10. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Haemophilus Influenzae Type B Injection Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2026) & (K Units) Table 15. North America Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2026) & (K Units) Table 17. Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Haemophilus Influenzae Type B Injection Vaccine Industry Trends Table 25. Haemophilus Influenzae Type B Injection Vaccine Industry Drivers Table 26. Haemophilus Influenzae Type B Injection Vaccine Industry Opportunities and Challenges Table 27. Haemophilus Influenzae Type B Injection Vaccine Industry Restraints Table 28. Global Haemophilus Influenzae Type B Injection Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Company (2021-2026) & (K Units) Table 31. Global Haemophilus Influenzae Type B Injection Vaccine Sales Share by Company (2021-2026) Table 32. Global Haemophilus Influenzae Type B Injection Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Haemophilus Influenzae Type B Injection Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Haemophilus Influenzae Type B Injection Vaccine Major Company Production Sites and Headquarters Table 35. Global Haemophilus Influenzae Type B Injection Vaccine Company, Product Type & Application Table 36. Global Haemophilus Influenzae Type B Injection Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Haemophilus Influenzae Type B Injection Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Haemophilus Influenzae Type B Injection Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region (2021-2026) & (K Units) Table 41. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Haemophilus Influenzae Type B Injection Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Haemophilus Influenzae Type B Injection Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2026) & (K Units) Table 62. North America Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2026) & (K Units) Table 64. Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Bharat Biotech Company Information Table 72. Bharat Biotech Business Overview Table 73. Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 75. Bharat Biotech Recent Development Table 76. Biokangtai Company Information Table 77. Biokangtai Business Overview Table 78. Biokangtai Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Biokangtai Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 80. Biokangtai Recent Development Table 81. Glaxosmithkline Company Information Table 82. Glaxosmithkline Business Overview Table 83. Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 85. Glaxosmithkline Recent Development Table 86. Olymvax Company Information Table 87. Olymvax Business Overview Table 88. Olymvax Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Olymvax Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 90. Olymvax Recent Development Table 91. Sanofi Pasteur Company Information Table 92. Sanofi Pasteur Business Overview Table 93. Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 95. Sanofi Pasteur Recent Development Table 96. Walvax Biotechnology Company Information Table 97. Walvax Biotechnology Business Overview Table 98. Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 100. Walvax Biotechnology Recent Development Table 101. Beijing Minhai Biotechnology Co., Ltd Company Information Table 102. Beijing Minhai Biotechnology Co., Ltd Business Overview Table 103. Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 105. Beijing Minhai Biotechnology Co., Ltd Recent Development Table 106. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Company Information Table 107. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Business Overview Table 108. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 110. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Development Table 111. Chengdu Oulin Biotechnology Co., Ltd Company Information Table 112. Chengdu Oulin Biotechnology Co., Ltd Business Overview Table 113. Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 115. Chengdu Oulin Biotechnology Co., Ltd Recent Development Table 116. Chengdu Institute of Biological Products Co., Ltd Company Information Table 117. Chengdu Institute of Biological Products Co., Ltd Business Overview Table 118. Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 120. Chengdu Institute of Biological Products Co., Ltd Recent Development Table 121. Lanzhou Institute of Biological Products Co., Ltd Company Information Table 122. Lanzhou Institute of Biological Products Co., Ltd Business Overview Table 123. Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 125. Lanzhou Institute of Biological Products Co., Ltd Recent Development Table 126. Yuxi Watson Biotechnology Co., Ltd Company Information Table 127. Yuxi Watson Biotechnology Co., Ltd Business Overview Table 128. Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 130. Yuxi Watson Biotechnology Co., Ltd Recent Development Table 131. North America Haemophilus Influenzae Type B Injection Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. North America Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026) & (K Units) Table 133. North America Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Country (2021-2026) Table 134. North America Haemophilus Influenzae Type B Injection Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 135. North America Haemophilus Influenzae Type B Injection Vaccine Sales Market Share Forecast by Country (2027-2032) Table 136. North America Haemophilus Influenzae Type B Injection Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Haemophilus Influenzae Type B Injection Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Haemophilus Influenzae Type B Injection Vaccine Market Share by Country (2021-2026) Table 139. North America Haemophilus Influenzae Type B Injection Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Haemophilus Influenzae Type B Injection Vaccine Market Share Forecast by Country (2027-2032) Table 141. Europe Haemophilus Influenzae Type B Injection Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026) & (K Units) Table 143. Europe Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Country (2021-2026) Table 144. Europe Haemophilus Influenzae Type B Injection Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 145. Europe Haemophilus Influenzae Type B Injection Vaccine Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Haemophilus Influenzae Type B Injection Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Haemophilus Influenzae Type B Injection Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Haemophilus Influenzae Type B Injection Vaccine Market Share by Country (2021-2026) Table 149. Europe Haemophilus Influenzae Type B Injection Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Haemophilus Influenzae Type B Injection Vaccine Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026) & (K Units) Table 153. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 155. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Market Share by Country (2021-2026) Table 159. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Market Share Forecast by Country (2027-2032) Table 161. Latin America Haemophilus Influenzae Type B Injection Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Latin America Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026) & (K Units) Table 163. Latin America Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Country (2021-2026) Table 164. Latin America Haemophilus Influenzae Type B Injection Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 165. Latin America Haemophilus Influenzae Type B Injection Vaccine Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Haemophilus Influenzae Type B Injection Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Haemophilus Influenzae Type B Injection Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Haemophilus Influenzae Type B Injection Vaccine Market Share by Country (2021-2026) Table 169. Latin America Haemophilus Influenzae Type B Injection Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Haemophilus Influenzae Type B Injection Vaccine Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026) & (K Units) Table 173. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 175. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Market Share by Country (2021-2026) Table 179. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Haemophilus Influenzae Type B Injection Vaccine Distributors List Table 184. Haemophilus Influenzae Type B Injection Vaccine Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Haemophilus Influenzae Type B Injection Vaccine Image Figure 2. Global Haemophilus Influenzae Type B Injection Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Haemophilus Influenzae Type B Injection Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Haemophilus Influenzae Type B Injection Vaccine Sales (2021-2032) & (K Units) Figure 5. Lyophilized Image Figure 6. Global Lyophilized Sales YoY Growth (2021-2032) & (K Units) Figure 7. Non-lyophilized Image Figure 8. Global Non-lyophilized Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Haemophilus Influenzae Type B Injection Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Haemophilus Influenzae Type B Injection Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Haemophilus Influenzae Type B Injection Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Haemophilus Influenzae Type B Injection Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Haemophilus Influenzae Type B Injection Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Haemophilus Influenzae Type B Injection Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Haemophilus Influenzae Type B Injection Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Haemophilus Influenzae Type B Injection Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Haemophilus Influenzae Type B Injection Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Haemophilus Influenzae Type B Injection Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Haemophilus Influenzae Type B Injection Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Haemophilus Influenzae Type B Injection Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Haemophilus Influenzae Type B Injection Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Haemophilus Influenzae Type B Injection Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Haemophilus Influenzae Type B Injection Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Haemophilus Influenzae Type B Injection Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Haemophilus Influenzae Type B Injection Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Haemophilus Influenzae Type B Injection Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Lyophilized
  • Non-lyophilized
Applications
  • Hospital
  • Clinic
Companies covered
  • Bharat Biotech
  • Biokangtai
  • Glaxosmithkline
  • Olymvax
  • Sanofi Pasteur
  • Walvax Biotechnology
  • Beijing Minhai Biotechnology Co., Ltd
  • Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
  • Chengdu Oulin Biotechnology Co., Ltd
  • Chengdu Institute of Biological Products Co., Ltd
  • Lanzhou Institute of Biological Products Co., Ltd
  • Yuxi Watson Biotechnology Co., Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Haemophilus Influenzae Type B Injection Vaccine Market by Type
  6. 1.3.1 Lyophilized
  7. 1.3.2 Non-lyophilized
  8. 1.4 Global Haemophilus Influenzae Type B Injection Vaccine Market Size by Type
  9. 1.4.1 Global Haemophilus Influenzae Type B Injection Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Haemophilus Influenzae Type B Injection Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Haemophilus Influenzae Type B Injection Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Haemophilus Influenzae Type B Injection Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Haemophilus Influenzae Type B Injection Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Haemophilus Influenzae Type B Injection Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Haemophilus Influenzae Type B Injection Vaccine Industry Trends
  2. 2.2 Haemophilus Influenzae Type B Injection Vaccine Industry Drivers
  3. 2.3 Haemophilus Influenzae Type B Injection Vaccine Industry Opportunities and Challenges
  4. 2.4 Haemophilus Influenzae Type B Injection Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Haemophilus Influenzae Type B Injection Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Haemophilus Influenzae Type B Injection Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Haemophilus Influenzae Type B Injection Vaccine Price (2021-2026)
  4. 3.4 Global Haemophilus Influenzae Type B Injection Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Haemophilus Influenzae Type B Injection Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Haemophilus Influenzae Type B Injection Vaccine Company, Product Type & Application
  7. 3.7 Global Haemophilus Influenzae Type B Injection Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Haemophilus Influenzae Type B Injection Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Haemophilus Influenzae Type B Injection Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Haemophilus Influenzae Type B Injection Vaccine Tier 1, Tier 2, and Tier 3
4 Haemophilus Influenzae Type B Injection Vaccine Regional Status and Outlook
  1. 4.1 Global Haemophilus Influenzae Type B Injection Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Haemophilus Influenzae Type B Injection Vaccine Historic Market Size by Region
  3. 4.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Haemophilus Influenzae Type B Injection Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Haemophilus Influenzae Type B Injection Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Haemophilus Influenzae Type B Injection Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Haemophilus Influenzae Type B Injection Vaccine by Application
  1. 5.1 Haemophilus Influenzae Type B Injection Vaccine Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Haemophilus Influenzae Type B Injection Vaccine Market Size by Application
  5. 5.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Haemophilus Influenzae Type B Injection Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Haemophilus Influenzae Type B Injection Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Haemophilus Influenzae Type B Injection Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Haemophilus Influenzae Type B Injection Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Haemophilus Influenzae Type B Injection Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bharat Biotech
  2. 6.1.1 Bharat Biotech Company Information
  3. 6.1.2 Bharat Biotech Business Overview
  4. 6.1.3 Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  6. 6.1.5 Bharat Biotech Recent Developments
  7. 6.2 Biokangtai
  8. 6.2.1 Biokangtai Company Information
  9. 6.2.2 Biokangtai Business Overview
  10. 6.2.3 Biokangtai Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Biokangtai Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  12. 6.2.5 Biokangtai Recent Developments
  13. 6.3 Glaxosmithkline
  14. 6.3.1 Glaxosmithkline Company Information
  15. 6.3.2 Glaxosmithkline Business Overview
  16. 6.3.3 Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  18. 6.3.5 Glaxosmithkline Recent Developments
  19. 6.4 Olymvax
  20. 6.4.1 Olymvax Company Information
  21. 6.4.2 Olymvax Business Overview
  22. 6.4.3 Olymvax Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Olymvax Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  24. 6.4.5 Olymvax Recent Developments
  25. 6.5 Sanofi Pasteur
  26. 6.5.1 Sanofi Pasteur Company Information
  27. 6.5.2 Sanofi Pasteur Business Overview
  28. 6.5.3 Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  30. 6.5.5 Sanofi Pasteur Recent Developments
  31. 6.6 Walvax Biotechnology
  32. 6.6.1 Walvax Biotechnology Company Information
  33. 6.6.2 Walvax Biotechnology Business Overview
  34. 6.6.3 Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  36. 6.6.5 Walvax Biotechnology Recent Developments
  37. 6.7 Beijing Minhai Biotechnology Co., Ltd
  38. 6.7.1 Beijing Minhai Biotechnology Co., Ltd Company Information
  39. 6.7.2 Beijing Minhai Biotechnology Co., Ltd Business Overview
  40. 6.7.3 Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  42. 6.7.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments
  43. 6.8 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
  44. 6.8.1 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Company Information
  45. 6.8.2 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Business Overview
  46. 6.8.3 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  48. 6.8.5 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Developments
  49. 6.9 Chengdu Oulin Biotechnology Co., Ltd
  50. 6.9.1 Chengdu Oulin Biotechnology Co., Ltd Company Information
  51. 6.9.2 Chengdu Oulin Biotechnology Co., Ltd Business Overview
  52. 6.9.3 Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  54. 6.9.5 Chengdu Oulin Biotechnology Co., Ltd Recent Developments
  55. 6.10 Chengdu Institute of Biological Products Co., Ltd
  56. 6.10.1 Chengdu Institute of Biological Products Co., Ltd Company Information
  57. 6.10.2 Chengdu Institute of Biological Products Co., Ltd Business Overview
  58. 6.10.3 Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  60. 6.10.5 Chengdu Institute of Biological Products Co., Ltd Recent Developments
  61. 6.11 Lanzhou Institute of Biological Products Co., Ltd
  62. 6.11.1 Lanzhou Institute of Biological Products Co., Ltd Company Information
  63. 6.11.2 Lanzhou Institute of Biological Products Co., Ltd Business Overview
  64. 6.11.3 Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  66. 6.11.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments
  67. 6.12 Yuxi Watson Biotechnology Co., Ltd
  68. 6.12.1 Yuxi Watson Biotechnology Co., Ltd Company Information
  69. 6.12.2 Yuxi Watson Biotechnology Co., Ltd Business Overview
  70. 6.12.3 Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  72. 6.12.5 Yuxi Watson Biotechnology Co., Ltd Recent Developments
7 North America by Country
  1. 7.1 North America Haemophilus Influenzae Type B Injection Vaccine Sales by Country
  2. 7.1.1 North America Haemophilus Influenzae Type B Injection Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Haemophilus Influenzae Type B Injection Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Haemophilus Influenzae Type B Injection Vaccine Market Size by Country
  6. 7.2.1 North America Haemophilus Influenzae Type B Injection Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Haemophilus Influenzae Type B Injection Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Haemophilus Influenzae Type B Injection Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Country
  2. 8.1.1 Europe Haemophilus Influenzae Type B Injection Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Haemophilus Influenzae Type B Injection Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Haemophilus Influenzae Type B Injection Vaccine Market Size by Country
  6. 8.2.1 Europe Haemophilus Influenzae Type B Injection Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Haemophilus Influenzae Type B Injection Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Haemophilus Influenzae Type B Injection Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Haemophilus Influenzae Type B Injection Vaccine Sales by Country
  2. 10.1.1 South America Haemophilus Influenzae Type B Injection Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Haemophilus Influenzae Type B Injection Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Haemophilus Influenzae Type B Injection Vaccine Market Size by Country
  6. 10.2.1 South America Haemophilus Influenzae Type B Injection Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Haemophilus Influenzae Type B Injection Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Haemophilus Influenzae Type B Injection Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Haemophilus Influenzae Type B Injection Vaccine Value Chain Analysis
  2. 12.1.1 Haemophilus Influenzae Type B Injection Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Haemophilus Influenzae Type B Injection Vaccine Production Mode & Process
  7. 12.2 Haemophilus Influenzae Type B Injection Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Haemophilus Influenzae Type B Injection Vaccine Distributors
  10. 12.2.3 Haemophilus Influenzae Type B Injection Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst